CN2682084Y - 快速筛选病原微生物敏感药物的装置 - Google Patents
快速筛选病原微生物敏感药物的装置 Download PDFInfo
- Publication number
- CN2682084Y CN2682084Y CN 200320131549 CN200320131549U CN2682084Y CN 2682084 Y CN2682084 Y CN 2682084Y CN 200320131549 CN200320131549 CN 200320131549 CN 200320131549 U CN200320131549 U CN 200320131549U CN 2682084 Y CN2682084 Y CN 2682084Y
- Authority
- CN
- China
- Prior art keywords
- box body
- screens
- pathogenic micro
- sensitive medicaments
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 118
- 244000000010 microbial pathogen Species 0.000 title claims abstract description 19
- 238000012216 screening Methods 0.000 title abstract description 11
- 229940079593 drug Drugs 0.000 claims description 46
- 238000003860 storage Methods 0.000 claims description 29
- 239000003550 marker Substances 0.000 claims description 14
- 239000007787 solid Substances 0.000 abstract description 15
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 238000003255 drug test Methods 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 42
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 42
- 238000012360 testing method Methods 0.000 description 23
- 239000002609 medium Substances 0.000 description 14
- 235000015097 nutrients Nutrition 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 6
- 239000003937 drug carrier Substances 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 208000031662 Noncommunicable disease Diseases 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 229960003405 ciprofloxacin Drugs 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229940049547 paraxin Drugs 0.000 description 3
- 235000010603 pastilles Nutrition 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- KIPLYOUQVMMOHB-MXWBXKMOSA-L [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O Chemical compound [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O KIPLYOUQVMMOHB-MXWBXKMOSA-L 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 2
- 229940063650 terramycin Drugs 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 1
- DHPRQBPJLMKORJ-XRNKAMNCSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O DHPRQBPJLMKORJ-XRNKAMNCSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 241000258957 Asteroidea Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 1
- 241001396957 Plectorhinchus cinctus Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000006063 cullet Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 229960000321 oxolinic acid Drugs 0.000 description 1
- 229960001732 pipemidic acid Drugs 0.000 description 1
- JOHZPMXAZQZXHR-UHFFFAOYSA-N pipemidic acid Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CN=C1N1CCNCC1 JOHZPMXAZQZXHR-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 description 1
- 229960003053 thiamphenicol Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940043263 traditional drug Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Images
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
状态 | 液体培养基中病原长势 | 选药方法 | |
a组样本 | b组样本 | ||
① | 良好 | 不好 | 以a组样本的药敏试验结果为主,b组样本的结果为参考 |
② | —— | 良好 | 以b组样本的药敏试验结果为主,a组样本的结果为参考 |
③ | 不好 | 不好 | 病原类型判定不对,更换培养基或检查是否疾病为非感染性疾病:病原为病毒等不能在培养基上生长的微生物。 |
编号 | 待选药物 | 编号 | 待选药物 | 编号 | 待选药物 | 编号 | 待选药物 |
1 | 土霉素 | 6 | 呋喃唑酮 | 11 | 卡那霉素 | 16 | 磺胺嘧啶 |
2 | 四环素 | 7 | 金霉素 | 12 | 氯霉素 | 17 | 甲砜霉素 |
3 | 庆大霉素 | 8 | 红霉素 | 13 | 青霉素 | 18 | 呋喃唑酮+TMP |
4 | 强力霉素 | 9 | 吡哌酸 | 14 | 环丙沙星 | 19 | 土霉素+TMP |
5 | 氟哌酸 | 10 | 恶喹酸 | 15 | 链霉素 | 20 | 链霉素+青霉素 |
编号 | 抑菌圈平均大小(cm) | 编号 | 抑菌圈平均大小(cm) | 编号 | 抑菌圈平均大小(cm) | 编号 | 抑菌圈平均大小(cm) |
1 | 0 | 6 | 0 | 11 | 0 | 16 | 0 |
2 | 0.3 | 7 | 0.2 | 12 | 2.0 | 17 | 1.6 |
3 | 0.5 | 8 | 0.4 | 13 | 0 | 18 | 0.7 |
4 | 0.5 | 9 | 1.2 | 14 | 2.0 | 19 | 0.5 |
5 | 1.4 | 10 | 1.5 | 15 | 0.7 | 20 | 0.7 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200320131549 CN2682084Y (zh) | 2003-12-30 | 2003-12-30 | 快速筛选病原微生物敏感药物的装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200320131549 CN2682084Y (zh) | 2003-12-30 | 2003-12-30 | 快速筛选病原微生物敏感药物的装置 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN2682084Y true CN2682084Y (zh) | 2005-03-02 |
Family
ID=34600138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200320131549 Expired - Lifetime CN2682084Y (zh) | 2003-12-30 | 2003-12-30 | 快速筛选病原微生物敏感药物的装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN2682084Y (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109112064A (zh) * | 2018-08-31 | 2019-01-01 | 泰州市春达动物药业饲料有限公司 | 一种应用于水产养殖的药敏试剂盒及其制备方法 |
-
2003
- 2003-12-30 CN CN 200320131549 patent/CN2682084Y/zh not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109112064A (zh) * | 2018-08-31 | 2019-01-01 | 泰州市春达动物药业饲料有限公司 | 一种应用于水产养殖的药敏试剂盒及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Metsoviti et al. | Effect of light intensity and quality on growth rate and composition of Chlorella vulgaris | |
Csuros | Microbiological examination of water and wastewater | |
Singh | A method of estimating the numbers of soil protozoa, especially amoebae, based on their differential feeding on bacteria | |
CN1109758C (zh) | 检测细菌的方法 | |
Fairbrother et al. | A Text-book of Bacteriology | |
JP2006526987A (ja) | 炭素13ラベル化バイオマス生産方法 | |
CN102492623A (zh) | 海水盾纤毛虫体外活体培养培养基的制备及培养方法 | |
CN2682084Y (zh) | 快速筛选病原微生物敏感药物的装置 | |
CN100480395C (zh) | 快速筛选病原微生物敏感药物的方法 | |
Zigo et al. | Effects of using an alternative bedding composition on the levels of indicator microorganisms and mammary health in dairy farm conditions | |
JP2009118785A (ja) | 底生性微細藻類の培養方法およびこれに利用する培養装置 | |
CN100338206C (zh) | 一种微生物培养基及其用途 | |
CN110235863B (zh) | 捻转血矛线虫体外培养方法 | |
CN111040953B (zh) | 一种基于pet成像系统快速筛选变异微生物的方法 | |
Mia et al. | A study on growth performance of Spirulina platensis in different concentrations of rotten apple as a carbon source | |
CN1295322C (zh) | 厌氧菌的阳性检测装置及厌氧菌的阳性检测方法 | |
Ward et al. | Gnotobiotics: A new discipline in biological and medical research | |
Wang et al. | Ecotoxicological effects of microplastics on bird embryo development by hatching without eggshell | |
RU2209829C2 (ru) | Способ культивирования микроорганизмов mycobacterium tuberculosis | |
CN214758511U (zh) | 一种适用于实验用动物的养护箱 | |
CN116267721A (zh) | 一种抗黑色素生成功效评价方法 | |
Boriyev et al. | BIOTECHNOLOGY OF CULTIVATION OF PHYTOPLANKTON AND ZOPLANKTON CONTAINING PHYSIOLOGICAL ACTIVE SUBSTANCES | |
CN2435400Y (zh) | 微生物敏感药物筛选盒 | |
CN109406345B (zh) | 一种药敏试验采样器及药敏试验方法 | |
RU2328526C1 (ru) | Способ выявления микобактерий туберкулеза крупного рогатого скота |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING DONGFANGTIANJIA TECHNOLOGY DEVELOPMENT CO Free format text: FORMER OWNER: YANG XIAOQIANG Free format text: FORMER OWNER: BEIJING DONGFANGTIANJIA TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20050429 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20050429 Address after: 15 box 100006, justice Road, post office, 7 East Main Street, Qianmen, Beijing Patentee after: Beijing Oriental TenGen Technology Development Co.,Ltd. Address before: 350026 Fujian Province, Fuzhou Cangshan District White Lake Pavilion Pu Road No. 105 Co-patentee before: Beijing Oriental TenGen Technology Development Co.,Ltd. Patentee before: Yang Xiaoqiang |
|
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Patentee address after: 100078 box 47, box 100078, Beijing Patentee address before: 15 box 100006, justice Road, post office, 7 East Main Street, Qianmen, Beijing |
|
AV01 | Patent right actively abandoned |
Effective date of abandoning: 20090422 |
|
AV01 | Patent right actively abandoned |
Effective date of abandoning: 20090422 |
|
C25 | Abandonment of patent right or utility model to avoid double patenting |